iifl-logo

Strides Pharma Science Ltd Historical Data

806
(1.49%)
Jun 10, 2025|10:39:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Strides Pharma Science Ltd Historical Data

10/05/2025calendar-icon
10/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-May-2025

655.8

667.1639.2651.3514,85223,48,47,819.51,49,081

13-May-2025

657

680.55654666.117,46916,88,21,494.451,20,668

14-May-2025

666

671.8655.8662.1511,45016,38,89,871.051,29,290

15-May-2025

663.5

669.6654.4665.714,57917,77,63,374.151,36,899

16-May-2025

669

675656.5661.4520,40624,29,77,357.21,80,296

19-May-2025

665

703660.05684.941,30365,32,57,818.44,42,730

20-May-2025

690

715.8680.05688.3540,48075,29,03,202.63,83,538

21-May-2025

694.35

703.75680.4695.5517,50927,79,16,920.61,88,517

22-May-2025

690.1

750680730.3588,8332,07,91,99,9387,93,234

23-May-2025

733

751.95718.35731.6552,0401,14,27,64,200.855,99,987

26-May-2025

734.7

748.95699.15705.535,38358,31,90,109.13,61,784

27-May-2025

709

724688.75713.131,57654,50,89,145.52,79,928

28-May-2025

715.5

721.65708.2715.121,68926,29,62,927.11,83,001

29-May-2025

716

794.8713.15781.31,12,2272,68,13,51,145.458,79,901

30-May-2025

786

816771.1811.152,2831,26,41,81,743.456,17,529

02-Jun-2025

816

828.3783792.564,5211,12,81,77,446.455,95,555

03-Jun-2025

793

809.95783.4789.826,78033,21,06,120.21,68,872

04-Jun-2025

792.7

796.05780.15790.7524,26924,93,62,003.81,33,216

05-Jun-2025

790.95

812.5783.25789.826,60634,71,86,994.751,34,777

06-Jun-2025

789.9

793.7775.15782.318,30033,74,05,471.351,55,880

09-Jun-2025

787.2

801782.15794.220,55630,23,35,393.351,64,993

Strides Pharma: Related NEWS

Strides Pharma Q3 Profit at ₹90 Crore, Revenue Up 15%
31 Jan 2025|11:55 AM

EBITDA grew 48% YoY at ₹210 crore, from ₹142 crore in the same quarter last year, marking better profitability.

Read More
Strides Pharma Posts ₹93 Crore Q2 Profit
28 Oct 2024|05:13 PM

EBITDA rose significantly to ₹235.7 Crore, a 54% increase from ₹153 Crore in the corresponding period of the previous year.

Read More
Strides Pharma gets shareholders’ approval for CDMO unit
11 Sep 2024|03:17 PM

In September 2023, the pharmaceutical behemoth revealed OneSource. The stock exchanges approved the idea earlier this year, in May.

Read More
Strides gets US FDA nod for Theophylline tablets
6 Sep 2024|12:18 PM

The medication is bioequivalent and therapeutically equivalent to Schering Corp's Reference Listed Drug (RLD), THEO-DUR.

Read More
Strides Pharma's Chennai Facility Receives USFDA Approval
19 Aug 2024|03:21 PM

The Alathur facility is key to Strides' global operations, especially in the US and other regulated markets, specializing in the production of tablets and capsules.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.